FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056462084> ?p ?o ?g. }

• W2056462084 endingPage "258" @default.
• W2056462084 startingPage "254" @default.
• W2056462084 abstract "Background Large cell neuroendocrine carcinoma (LCNEC) and small cell lung cancer (SCLC) are recognized as high-grade neuroendocrine carcinomas (HGNEC) of the lung. In patients with completely resected HGNEC, platinum-based adjuvant chemotherapy may be considered. However, the optimum chemotherapy regimen has not been determined. We conducted a multicenter single-arm phase II trial to evaluate irinotecan and cisplatin in postoperative adjuvant chemotherapy for HGNEC patients. Patients and methods Patients with completely resected stage I–IIIA HGNEC received four cycles of irinotecan (60 mg/m2, day 1, 8, 15) plus cisplatin (60 mg/m2, day 1). This regimen was repeated every 4 weeks. The primary endpoint was the rate of completion of chemotherapy (defined as having undergone three or four cycles), and secondary endpoints were the rate of 3-year relapse-free survival (RFS), rate of 3-year survival and toxicities. Results Forty patients were enrolled between September 2007 and April 2010. Patients’ characteristics were: median age (range) 65 [45–73] years; male 85%; ECOG-PS 1 60%; LCNEC 57% and SCLC 43%; stage IA/IB/IIB/IIIA 32/35/8/5%; 95% received lobectomy. The rate of completion of chemotherapy was 83% (90% C.I.; 71–90%). The rate of overall survival at 3 years was estimated at 81%, and that of RFS at 3 years was 74%. The rates of overall survival and RFS at 3 years were 86 and 74% among 23 LCNEC patients, and 74 and 76% among 17 SCLC patients, respectively. Nineteen patients (48%) experienced grade 3 or 4 neutropenia, but only five patients (13%) developed febrile neutropenia. Two patients (5%) developed grade 3 diarrhea, and four patients (10%) had grade 3 nausea. No treatment-related deaths were observed in this study. All 40 specimens were also diagnosed as HGNEC by central pathological review. Conclusions The combination of irinotecan and cisplatin as postoperative adjuvant chemotherapy was feasible and possibly efficacious for resected HGNEC." @default.
• W2056462084 created "2016-06-24" @default.
• W2056462084 creator A5019998656 @default.
• W2056462084 creator A5020448557 @default.
• W2056462084 creator A5021359572 @default.
• W2056462084 creator A5032337115 @default.
• W2056462084 creator A5034162457 @default.
• W2056462084 creator A5042783545 @default.
• W2056462084 creator A5043607755 @default.
• W2056462084 creator A5050668107 @default.
• W2056462084 creator A5051611223 @default.
• W2056462084 creator A5060063956 @default.
• W2056462084 creator A5077569776 @default.
• W2056462084 creator A5078552758 @default.
• W2056462084 creator A5091584502 @default.
• W2056462084 date "2014-06-01" @default.
• W2056462084 modified "2023-09-29" @default.
• W2056462084 title "A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer)" @default.
• W2056462084 cites W1965940143 @default.
• W2056462084 cites W2002873037 @default.
• W2056462084 cites W2029984578 @default.
• W2056462084 cites W2040759077 @default.
• W2056462084 cites W2049089014 @default.
• W2056462084 cites W2070469586 @default.
• W2056462084 cites W2073683299 @default.
• W2056462084 cites W2079867585 @default.
• W2056462084 cites W2080283495 @default.
• W2056462084 cites W2083709473 @default.
• W2056462084 cites W2086712510 @default.
• W2056462084 cites W2092880698 @default.
• W2056462084 cites W2107058542 @default.
• W2056462084 cites W2108814287 @default.
• W2056462084 cites W2110391705 @default.
• W2056462084 cites W2117756825 @default.
• W2056462084 cites W2118948610 @default.
• W2056462084 cites W2127342594 @default.
• W2056462084 cites W2130503509 @default.
• W2056462084 cites W2141956703 @default.
• W2056462084 cites W2149301055 @default.
• W2056462084 cites W2151090489 @default.
• W2056462084 cites W2156202615 @default.
• W2056462084 cites W2158234609 @default.
• W2056462084 cites W2166418266 @default.
• W2056462084 cites W2170260373 @default.
• W2056462084 cites W2228146597 @default.
• W2056462084 doi "https://doi.org/10.1016/j.lungcan.2014.03.007" @default.
• W2056462084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24679951" @default.
• W2056462084 hasPublicationYear "2014" @default.
• W2056462084 type Work @default.
• W2056462084 sameAs 2056462084 @default.
• W2056462084 citedByCount "29" @default.
• W2056462084 countsByYear W20564620842015 @default.
• W2056462084 countsByYear W20564620842016 @default.
• W2056462084 countsByYear W20564620842017 @default.
• W2056462084 countsByYear W20564620842018 @default.
• W2056462084 countsByYear W20564620842019 @default.
• W2056462084 countsByYear W20564620842020 @default.
• W2056462084 countsByYear W20564620842021 @default.
• W2056462084 countsByYear W20564620842022 @default.
• W2056462084 crossrefType "journal-article" @default.
• W2056462084 hasAuthorship W2056462084A5019998656 @default.
• W2056462084 hasAuthorship W2056462084A5020448557 @default.
• W2056462084 hasAuthorship W2056462084A5021359572 @default.
• W2056462084 hasAuthorship W2056462084A5032337115 @default.
• W2056462084 hasAuthorship W2056462084A5034162457 @default.
• W2056462084 hasAuthorship W2056462084A5042783545 @default.
• W2056462084 hasAuthorship W2056462084A5043607755 @default.
• W2056462084 hasAuthorship W2056462084A5050668107 @default.
• W2056462084 hasAuthorship W2056462084A5051611223 @default.
• W2056462084 hasAuthorship W2056462084A5060063956 @default.
• W2056462084 hasAuthorship W2056462084A5077569776 @default.
• W2056462084 hasAuthorship W2056462084A5078552758 @default.
• W2056462084 hasAuthorship W2056462084A5091584502 @default.
• W2056462084 hasConcept C121608353 @default.
• W2056462084 hasConcept C126322002 @default.
• W2056462084 hasConcept C143998085 @default.
• W2056462084 hasConcept C203092338 @default.
• W2056462084 hasConcept C2776256026 @default.
• W2056462084 hasConcept C2776283816 @default.
• W2056462084 hasConcept C2776694085 @default.
• W2056462084 hasConcept C2777063308 @default.
• W2056462084 hasConcept C2778239845 @default.
• W2056462084 hasConcept C2778336483 @default.
• W2056462084 hasConcept C2779292878 @default.
• W2056462084 hasConcept C2780259306 @default.
• W2056462084 hasConcept C2781413609 @default.
• W2056462084 hasConcept C526805850 @default.
• W2056462084 hasConcept C535046627 @default.
• W2056462084 hasConcept C71924100 @default.
• W2056462084 hasConcept C90924648 @default.
• W2056462084 hasConceptScore W2056462084C121608353 @default.
• W2056462084 hasConceptScore W2056462084C126322002 @default.
• W2056462084 hasConceptScore W2056462084C143998085 @default.
• W2056462084 hasConceptScore W2056462084C203092338 @default.
• W2056462084 hasConceptScore W2056462084C2776256026 @default.
• W2056462084 hasConceptScore W2056462084C2776283816 @default.
• W2056462084 hasConceptScore W2056462084C2776694085 @default.
• W2056462084 hasConceptScore W2056462084C2777063308 @default.

• next